Article Information
History
- January 6, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Andreas Puyskens1,*,
- Janine Michel1,
- Anna Stoliaroff-Pépin2,
- Fatimanur Bayram1,
- Akin Sesver1,
- Ole Wichmann2,
- Thomas Harder2,
- Lars Schaade1,
- Andreas Nitsche1 and
- Caroline Peine2
- 1Highly Pathogenic Viruses, Centre for Biological Threats and Special Pathogens, WHO Reference Laboratory for SARS-CoV-2 and WHO Collaborating Centre for Emerging Infections and Biological Threats, Robert Koch Institute, Berlin, Germany
- 2Department for Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Berlin, Germany
- ↵*Correspondence: Andreas Puyskens (PuyskensA@rki.de)